PF
Fontana, Pierre
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants | Frontiers in pharmacology | 2026 | 5 | 7 | |||
| MicroRNA-223-3p is a determinant of platelet procoagulant activity | Blood advances | 2026 | 19 | 77 | |||
| Different D-dimer assays with age-adjusted cutoffs to exclude pulmonary embolism : secondary analysis of ADJUST-PE study | Journal of thrombosis and haemostasis | 2025 | 11 | 234 | |||
| Expertise et proximité : duo clé de la prise en charge vasculaire | Revue médicale suisse | 2025 | 6 | 0 | |||
| Management of bleeding and invasive procedures in patients treated with anti-factor XI(a) anticoagulants : proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis | Research and practice in thrombosis and haemostasis | 2025 | 6 | 108 | |||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology | 2025 | 81 | 0 | |||
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 110 | 28 | |||
| Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature | Research and practice in thrombosis and haemostasis | 2024 | 124 | 147 | |||
| Recherche de l’anticoagulant idéal : beaucoup de progrès et quelques surprises | Revue médicale suisse | 2024 | 17 | 0 | |||
| Systemic thrombolysis for a mechanical atrioventricular valve thrombosis in a child with a single-ventricle palliation at Fontan stage | JTCVS techniques | 2024 | 36 | 79 | |||
| Saignements utérins anormaux et anomalies de l’hémostase | Revue médicale suisse | 2024 | 31 | 5 | |||
| Prevention of perioperative venous thromboembolism : 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network | Anaesthesia critical care & pain medicine | 2024 | 33 | 154 | |||
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | 2023 | 125 | 97 | |||
| Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology | Journal of thrombosis and haemostasis | 2023 | 79 | 0 | |||
| Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology | Swiss medical weekly | 2023 | 95 | 423 | |||
| Thrombophilia and outcomes of venous thromboembolism in older patients | Research and practice in thrombosis and haemostasis | 2023 | 95 | 69 | |||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | 2023 | 147 | 464 | |||
| Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe | Haemophilia | 2023 | 71 | 0 | |||
| Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator | Diagnostics | 2023 | 79 | 145 | |||
| Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding | Blood coagulation & fibrinolysis | 2023 | 78 | 0 | |||
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | 2023 | 120 | 208 | |||
| Le pouvoir des itinéraires cliniques : assurer une gestion optimale | Revue médicale suisse | 2023 | 86 | 45 | |||
| Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology | Fertility and sterility | 2023 | 143 | 0 | |||
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | 2023 | 320 | 87 | |||
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC anesthesiology | 2023 | 98 | 231 | |||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | 2023 | 135 | 427 | |||
| Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group | Haemophilia | 2023 | 98 | 0 | |||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | 2022 | 290 | 582 | |||
| Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study | Life | 2022 | 125 | 80 | |||
| Angiologie-hémostase - Année 2021 : morceaux choisis | Revue médicale suisse | 2022 | 100 | 115 | |||
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | 2022 | 141 | 203 | |||
| Vers de nouveaux anticoagulants | Revue médicale suisse | 2022 | 75 | 89 | |||
| Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study | Frontiers in cardiovascular medicine | 2022 | 113 | 173 | |||
| External validation of the MidiCAT variant of thrombography: Comparison with calibrated automated thrombography and study of the centrifugation scheme | Frontiers in cardiovascular medicine | 2022 | 101 | 86 | |||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | 2022 | 251 | 301 | |||
| New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia | Thrombosis and haemostasis | 2022 | 159 | 0 | |||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | 2022 | 166 | 290 | |||
| Saignements d’origine indéterminée : approche diagnostique et thérapeutique | Revue médicale suisse | 2022 | 89 | 343 | |||
| Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of Geneva | BMJ open | 2022 | 146 | 144 | |||
| The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology | Journal of Thrombosis and Haemostasis | 2021 | 276 | 0 | |||
| miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa | Thrombosis and haemostasis | 2021 | 104 | 107 | |||
| Do miRNAs Have a Role in Platelet Function Regulation? | Hämostaseologie | 2021 | 211 | 1 | |||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | 2021 | 178 | 0 | |||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | 2021 | 288 | 5 | |||
| Détection de l’athérosclérose asymptomatique, y-a-t-il une place en pratique quotidienne ? | Revue médicale suisse | 2021 | 67 | 64 | |||
| Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements | Frontiers in cardiovascular medicine | 2021 | 170 | 186 | |||
| A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation | British Journal of Haematology | 2021 | 353 | 222 | |||
| Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis | Journal of Thrombosis and Haemostasis | 2021 | 277 | 1 | |||
| An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional Pharmacogenetics | Journal of Personalized Medicine | 2021 | 253 | 272 | |||
| COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies | Journal of thrombosis and haemostasis | 2021 | 92 | 100 | |||
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | 2020 | 544 | 251 | |||
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | 2020 | 347 | 242 | |||
| Platelet function test use for patients with coronary artery disease in the early 2020s | Journal of clinical medicine | 2020 | 201 | 186 | |||
| Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium | Clinical Pharmacology and Therapeutics | 2020 | 205 | 114 | |||
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | 2020 | 314 | 350 | |||
| Platelet Transforming Growth Factor-β1 Induces Liver Sinusoidal Endothelial Cells to Secrete Interleukin-6 | Cells | 2020 | 368 | 205 | |||
| Implémentation des stratégies diagnostiques de l’embolie pulmonaire : encore et toujours un défi | Revue médicale suisse | 2020 | 6 | 12 | |||
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | 2020 | 342 | 381 | |||
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | 2020 | 281 | 318 | |||
| Platelet Interactions with Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells Lead to Hepatocyte Proliferation | Cells | 2020 | 362 | 131 | |||
| Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 | Swiss Medical Weekly | 2020 | 370 | 810 | |||
| An unusual thrombus location in a Heartmate 3TM device with fatal outcome | Perfusion | 2020 | 311 | 1 | |||
| Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland | Swiss Medical Weekly | 2020 | 619 | 355 | |||
| Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab | Swiss medical weekly | 2020 | 201 | 127 | |||
| Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations | Journal of Thrombosis and Haemostasis | 2020 | 211 | 0 | |||
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | 2020 | 293 | 1 | |||
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | 2020 | 250 | 190 | |||
| Maladies vasculaires périphériques et prévention secondaire : un appel à agir | Revue médicale suisse | 2019 | 241 | 222 | |||
| Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review | Haemophilia | 2019 | 433 | 1 | |||
| Platelets and Platelet‐Derived Extracellular Vesicles in Liver Physiology and Disease | Hepatology Communications | 2019 | 502 | 389 | |||
| Selective inhibition of Panx1 channels decreases hemostasis and thrombosis in vivo | Thrombosis Research | 2019 | 413 | 208 | |||
| A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study | Journal of Proteomics | 2019 | 530 | 544 | |||
| Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells | Thrombosis and Haemostasis | 2019 | 515 | 507 | |||
| Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP) | Haemophilia | 2019 | 266 | 0 | |||
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | 2019 | 392 | 192 | |||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | 2019 | 505 | 2 | |||
| Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms | Thrombosis and Haemostasis | 2019 | 256 | 0 | |||
| Platelet Function Testing or Genotyping: Which Should We Trust? | JACC: Cardiovascular Interventions | 2019 | 222 | 0 | |||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 739 | 877 | |||
| Fermeture du foramen ovale perméable : où en sommes-nous en 2018 ? | Revue médicale suisse | 2018 | 273 | 0 | |||
| Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC) | American Heart Journal | 2018 | 494 | 263 | |||
| Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model | European Journal of Anaesthesiology | 2018 | 484 | 5 | |||
| Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016 | Anaesthesia Critical Care & Pain Medicine | 2018 | 602 | 445 | |||
| Angiology and haemostasis. Highlights on some new data in 2017 | Revue médicale suisse | 2018 | 390 | 94 | |||
| Platelet reactivity in stable cardiovascular patients with chronic kidney disease | Platelets | 2018 | 528 | 0 | |||
| Traitements antithrombotiques et anomalies constitutionnelles hémorragipares de l'hémostase | Revue médicale suisse | 2018 | 376 | 169 | |||
| Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT | Archives of Cardiovascular Diseases | 2018 | 433 | 3 | |||
| Anticoagulation à faible dose : is less more ? | Revue médicale suisse | 2018 | 284 | 127 | |||
| Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation | Vox Sanguinis | 2018 | 480 | 3 | |||
| Shotgun proteomics data on the impact of hyperglycaemia on platelet protein acetylation by aspirin | Data in Brief | 2018 | 494 | 212 | |||
| Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation | Journal of Visualized Experiments | 2017 | 548 | 1 | |||
| Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? | American Journal of Medicine | 2017 | 509 | 0 | |||
| Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study | Haemophilia | 2017 | 489 | 0 | |||
| Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015 | Anaesthesia critical care & pain medicine | 2017 | 525 | 0 | |||
| Impact of rivaroxaban on point-of-care assays | Thrombosis research | 2017 | 471 | 0 | |||
| Platelets in liver regeneration | ISBT Science Series | 2017 | 516 | 4 | |||
| Angiologie et hémostase | Revue médicale suisse | 2017 | 433 | 133 | |||
| Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia A | Haemophilia | 2017 | 390 | 0 | |||
| A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system | Journal of thrombosis and haemostasis | 2017 | 599 | 3 | |||
| Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring | Frontiers in Pharmacology | 2017 | 486 | 222 | |||
| Thromboses veineuses splanchniques | Revue médicale suisse | 2017 | 444 | 256 | |||
| Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function | International journal of molecular sciences | 2017 | 588 | 303 | |||
| TiN x O y coatings facilitate the initial adhesion of osteoblasts to create a suitable environment for their proliferation and the recruitment of endothelial cells | Biomedical materials | 2017 | 799 | 3 | |||
| Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels | Journal of Thrombosis and Haemostasis | 2017 | 478 | 0 | |||
| Le défi des maladies vasculaires rares : l'union fait la force ! | Revue médicale suisse | 2017 | 333 | 169 | |||
| Impact of pneumatic tube system transport for the monitoring of heparin therapy | Thrombosis Research | 2017 | 468 | 0 | |||
| Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients | Cell communication & adhesion | 2017 | 575 | 2 | |||
| Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study | British journal of clinical pharmacology | 2016 | 509 | 0 | |||
| Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential | Journal of biomaterials applications | 2016 | 874 | 3 | |||
| Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data | Thrombosis and haemostasis | 2016 | 581 | 284 | |||
| Genetics of clopidogrel poor-response | Antiplatelet Therapy in Cardiovascular Disease | 2016 | 518 | 0 | |||
| New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach | Human genetics | 2016 | 836 | 327 | |||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | 2016 | 512 | 255 | |||
| PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients | Stroke | 2016 | 561 | 0 | |||
| Anticoagulants oraux directs (ACOD) : une aide à la prescription dans la pratique quotidienne | Revue médicale suisse | 2016 | 484 | 480 | |||
| Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model | Transfusion | 2016 | 519 | 2 | |||
| Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | 2016 | 716 | 1 | |||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 671 | 1,043 | |||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 626 | 0 | |||
| La maladie thromboembolique veineuse : une pathologie souvent oubliée | Revue médicale suisse | 2016 | 425 | 303 | |||
| TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke | Stroke | 2016 | 529 | 0 | |||
| Direct oral anticoagulants: a guide for daily practice | Schweizerische medizinische Wochenschrift | 2016 | 813 | 417 | |||
| News in angiology and hemostasis | Revue médicale suisse | 2016 | 567 | 166 | |||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | 2016 | 772 | 710 | |||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | 2016 | 537 | 0 | |||
| Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ? | Schweizerische medizinische Wochenschrift | 2016 | 637 | 316 | |||
| Laboratory testing of Hemostasis | Perioperative Hemostasis | 2015 | 437 | 351 | |||
| Direct oral anticoagulants: efficacy and safety in patient subgroups | Schweizerische medizinische Wochenschrift | 2015 | 810 | 459 | |||
| Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation | Thrombosis and haemostasis | 2015 | 656 | 10 | |||
| A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? | Journal of hepatology | 2015 | 890 | 0 | |||
| Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? | Expert opinion on pharmacotherapy | 2015 | 683 | 2 | |||
| Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants | Critical care | 2015 | 527 | 431 | |||
| Reply to: "The role of platelets in liver regeneration - What don't we know?" | Journal of hepatology | 2015 | 491 | 0 | |||
| Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | 2015 | 648 | 6 | |||
| Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma | Thrombosis research | 2015 | 506 | 1,915 | |||
| Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins | Journal of proteomics | 2015 | 741 | 1 | |||
| Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation | EuPA open proteomics | 2015 | 558 | 379 | |||
| The Human Diabetes Proteome Project (HDPP): The 2014 update | Translational proteomics | 2015 | 632 | 318 | |||
| Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study | Platelets | 2015 | 586 | 0 | |||
| Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? | Platelets | 2015 | 685 | 3 | |||
| Fibrin degradation during sonothrombolysis – Effect of ultrasound, microbubbles and tissue plasminogen activator | Journal of drug delivery science and technology | 2015 | 579 | 0 | |||
| Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor | A & A case reports | 2015 | 654 | 1 | |||
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | 2014 | 586 | 0 | |||
| How to manage prasugrel and ticagrelor in daily practice | European journal of internal medicine | 2014 | 508 | 800 | |||
| Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | 2014 | 652 | 2 | |||
| Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study | EuPA open proteomics | 2014 | 502 | 278 | |||
| Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assays | Applied surface science | 2014 | 804 | 4 | |||
| Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies | Journal of thrombosis and haemostasis | 2014 | 618 | 0 | |||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | 2014 | 662 | 3 | |||
| Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | 2014 | 675 | 0 | |||
| Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood | Thrombosis research | 2014 | 621 | 2 | |||
| Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules | Journal of proteomics | 2014 | 796 | 3 | |||
| Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism | European heart journal | 2014 | 634 | 338 | |||
| Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia | Haematologica | 2014 | 633 | 2 | |||
| Predicting deep venous thrombosis in pregnancy : external validation of the LEFT clinical prediction rule | Haematologica | 2013 | 66 | 312 | |||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | 2013 | 413 | 0 | |||
| The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and prevention | Translational proteomics | 2013 | 719 | 307 | |||
| Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2013 | 595 | 0 | |||
| Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013 | Archives of cardiovascular diseases | 2013 | 541 | 0 | |||
| Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? | Revue médicale suisse | 2013 | 588 | 0 | |||
| Gestion péri-interventionnelle des nouveaux agents antiplaquettaires | Revue médicale suisse | 2013 | 655 | 397 | |||
| Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ? | Revue médicale suisse | 2013 | 564 | 1 | |||
| Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management | Journal of thrombosis and haemostasis | 2013 | 692 | 0 | |||
| Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm | Translational proteomics | 2013 | 662 | 610 | |||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | 2012 | 738 | 102 | |||
| Aspirin for venous thromboembolism prevention and treatment: a renewal? | Polskie Archiwum Medycyny Wewnętrznej | 2012 | 585 | 380 | |||
| Prevalence of poor biological response to clopidogrel: a systematic review | Thrombosis and haemostasis | 2012 | 554 | 0 | |||
| Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management | Cardiovascular therapeutics | 2012 | 635 | 0 | |||
| Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2012 | 625 | 0 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 593 | 0 | |||
| Platelet proteomics | Mass spectrometry reviews | 2012 | 548 | 2 | |||
| The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin | Journal of thrombosis and haemostasis | 2011 | 576 | 0 | |||
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | 2011 | 640 | 0 | |||
| Surveillance biologique des héparines et du fondaparinux | Revue médicale suisse | 2011 | 620 | 4 | |||
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | 2011 | 654 | 0 | |||
| Connexin 37 limits thrombus propensity by downregulating platelet reactivity | Circulation | 2011 | 778 | 978 | |||
| Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 677 | 0 | |||
| Hémostase. Le point sur les nouveaux antithrombotiques | Revue médicale suisse | 2010 | 544 | 0 | |||
| Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2010 | 586 | 0 | |||
| Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique | Revue médicale suisse | 2010 | 609 | 0 | |||
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | 2010 | 522 | 0 | |||
| Antiagregants plaquettaires : lequel, quand et pour qui ? | La Revue de médecine interne | 2010 | 512 | 0 | |||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | 2010 | 608 | 0 | |||
| Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance | Current vascular pharmacology | 2009 | 533 | 0 | |||
| Cell-derived microparticles in haemostasis and vascular medicine | Thrombosis and haemostasis | 2009 | 559 | 0 | |||
| Diagnosis of mild bleeding disorders | Schweizerische medizinische Wochenschrift | 2009 | 643 | 1,184 | |||
| Intercellular communication in atherosclerosis | Physiology | 2009 | 641 | 98 | |||
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | 2009 | 564 | 0 | |||
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | 2009 | 526 | 0 | |||
| No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro | Journal of Cellular and Molecular Medicine | 2009 | 575 | 0 | |||
| Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness | Thrombosis research | 2008 | 634 | 0 | |||
| Impending paradoxical embolism. When and how to treat? | Annales de cardiologie et d'angéiologie | 2008 | 594 | 0 | |||
| Assessing aspirin responsiveness using the Verify Now Aspirin assay | Thrombosis research | 2008 | 648 | 0 | |||
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2008 | 664 | 0 | |||
| Laboratory-defined aspirin resistance and recurrent cardiovascular events | Archives of internal medicine | 2008 | 583 | 0 | |||
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | 2008 | 539 | 1 | |||
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | 2008 | 610 | 0 | |||
| Skin necrosis is a clinical manifestation of low-molecular weight heparin-induced thrombocytopenia | Thrombosis and haemostasis | 2004 | 43 | 0 | |||
| Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects | Circulation | 2003 | 341 | 229 |
